Clinical trial
Feasibility, Acceptability, Effectiveness and Cost-analysis of Models of HCV Viremia Testing for Confirmation and Cure Among People Who Inject Drugs (PWID): the HEAD*-Start Trial in Georgia
NCT03594838 is registered in ClinicalTrials.gov with Foundation for Innovative New Diagnostics, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility, Acceptability, Effectiveness and Cost-analysis of Models of HCV Viremia Testing for Confirmation and Cure Among People Who Inject Drugs (PWID): the HEAD*-Start Trial in Georgia
- Lead sponsor
- Foundation for Innovative New Diagnostics, Switzerland
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 21, 2018
- Completion date
- July 21, 2020
- Enrollment
- 1,672 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.